Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Canaan Inc. (“Canaan” or the...
Shareholder rights law firm Robbins LLP announces that a purchaser of Canaan Inc. (NASDAQ: CAN) filed a class action complaint for alleged violations of the Securities Exchange Act of 1933...
Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of Canaan Inc. (NASDAQ: CAN) for alleged violations of the Securities Exchange Act of 1933...
The law firm of Kirby McInerney LLP is investigating potential claims against Canaan Inc. (“Canaan” or the “Company”) (NASDAQ: CAN). This investigation concerns whether Canaan has violated...
The law firm of Kirby McInerney LLP is investigating potential claims against Canaan Inc. (“Canaan” or the “Company”) (NASDAQ: CAN). This investigation concerns whether Canaan has violated...
The Law Offices of Frank R. Cruz announces an investigation on behalf of Canaan Inc. (“Canaan” or the “Company”) (NASDAQ: CAN) investors concerning the Company and its officers’ possible...
Candie's, Inc., (NASDAQ: CAND) (the "Company") announced today that effective July 1st it will change its corporate name to Iconix Brand Group, Inc. ("Iconix") and will trade on the NASDAQ...
Badgley Mischka(R), a division of Candie's Inc., (NASDAQ: CAND) announced today a license agreement with Groupe JS International for a bridge apparel collection to launch for Spring 2006. The...
Candie's, Inc. (NASDAQ: CAND) (the "Company") announced today it has entered into a retail license agreement with Pristine Fashion Group ("Pristine Fashion") for its Badgley Mischka(R...
Candie's, Inc., (NASDAQ: CAND) "the Company" announced today it has entered into a long-term worldwide license agreement with Toronto-based, Riviera Concepts, Inc. ("Riviera") for its...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| NVDANVIDIA Corporation | US$ 128,99 (8,93%) | 567,37M |
| TNXPTonix Pharmaceuticals Holding Corporation | US$ 0,46005 (11,64%) | 381,46M |
| HEPAHepion Pharmaceuticals Inc | US$ 0,2192 (32,85%) | 314,81M |
| SLXNSilexion Therapeutics Corporation | US$ 1,335 (130,17%) | 237,62M |
| JBLUJetBlue Airways Corporation | US$ 6,01 (-25,71%) | 124,58M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
